Accuretic 20/12.5mg Quinapril/HCTZ 30 Tablets/Pack Quinapril. Initial: 10 mg/12.5 mg or 20 mg/12.5 mg PO q Day Increase either or both components based on clinical response Do not increase hydrocorothiazide component more often than q 2-3 weeks To minimize dose-independent side effects, it is usually appropriate to initiate combination therapy only after inadequate response to quinapril monotherapy or snificant potassium loss resulting from hydrocorothiazide monotherapy Hypersensitivity to either component or sulfonamides History of hereditary or angioedema associated with previous ACE inhibitor treatment Do not coadminister with aliskiren in patients with diabetes mellitus or with renal impairment (ie, GFR Dual blockade of the renin angiotensin system with ARBs, ACE inhibitors, or aliskiren associated with increased risk for hypotension, hyperkalemia, and renal function changes (including acute renal failure) compared to monotherapy May aggravate ditalis toxicity Sensitivity reactions may occur with or without history of allergy or asthma Risk of male sexual dysfunction Renal impairment may occur Acute transient myopia and acute angle-closure glaucoma has been reported, particularly with history of sulfonamide or penicillin allergy (hydrocorothiazide is a sulfonamide) Angioedema of the face, extremities, lips, tongue, glottis, and larynx has been reported in patients treated with angiotensin-converting enzyme inhibitors If laryngeal stridor or angioedema of the face, tongue, or glottis occurs discontinue therapy and institute appropriate therapy immediately Patients receiving coadministration of ACE inhibitor and m TOR (mammalian target of rapamycin) inhibitor (eg, temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema Intestinal angioedema has been reported in patients treated with ACE inhibitors Cholestatic jaundice may occur, which may progress to fulminant hepatic necrosis; discontinue Dry hacking nonproductive cough may occur within few months of treatment; consider other causes of cough prior to discontinuation Hyperkalemia may occur with ACE inhibitors; risk factors include renal dysfunction, diabetes mellitus, and concomitant use of potassium sparing diuretics and potassium supplements; use cautiously if at all with these agents Thiazide diuretics may cause hypokalemia, hypocoremic alkalosis, hypomagnesemia, and hyponatremia Hydrocorothiazide may precipitate gout in patients with familial predisposition to gout or chronic renal failure Symptomatic hypotension with or without syncope can occur with ACE inhibitors; mostly observed in volume depleted patients, correct volume depletion prior to initiation; monitor closely when initiating and increasing dosing Agranulocytosis, neutropenia, or leukopenia with myeloid hypoplasia reported with other ACE inhibitor; patients with renal impairment are at hh risk; monitor CBC with differential in these patients Photosensitization may occur Hydrocorothiazide may cause acute transient myopia and acute angle-closure glaucoma that may occur within hours of initiating therapy; discontinue therapy immediately in patients with acute decreases in visual acuity or ocular pain; additional treatment may be needed if uncontrolled intraocular pressure persists Use caution in patients with severe aortic stenosis; may reduce coronary perfusion resulting in ischemia Use hydrocorothiazide with caution in patients with diabetes or at risk of diabetes; may see increase in glucose Use caution in patients collagen vascular disease, especially in patients with concomitant renal impairment Thiazide diuretics may decrease renal calcium excretion; consider avoiding use in patients with hypercalcemia Accuretic is a fixed-combination tablet that combines an angiotensin-converting enzyme (ACE) inhibitor, quinapril hydrocoride, and a thiazide diuretic, hydrocorothiazide Quinapril competitively inhibits angiotensin-converting enzymes resulting in decreased plasma angiotensin II concentrations and consequently, blood pressure may be reduced in part through decreased vasoconstriction, increase renin activity, and decrease aldosterone secretion Hydrocorothiazide is a thiazide diuretic that inhibits Na reabsorption in distal renal tubules resulting in increased excretion of Na and water, also K and H ions The above information is provided for general informational and educational purposes only. Accuretic tablets are used to treat hypertension. They contain quinapril and hydrocorothiazide and you can buy Accuretic online from
ACE inhibitor and thiazide combination - pedia Individual plans may vary and formulary information changes. An ACE inhibitor and thiazide combination is a drug combination used to treat hypertension. They are given by oral administration. Contents. hide. 1 Examples. 1.1 Fosinopril/hydrocorothiazide. 2 See also; 3 References. Examplesedit. Enalapril/hydrocorothiazide trade name Enalapril comp, wherein. Quinapril/hydrocorothiazide trade name Accuretic is manufactured by.
Accuretic hydrocorothiazide/quinapril hydrocoride dose. You should not use this medication if you are allergic to any other ACE inhibitor, such as benazepril (Lotensin), captopril (Capoten), fosinopril (Monopril), enalapril (Vasotec), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), or trandolapril (Mavik). Hydrocorothiazide; quinapril is classified as FDA pregnancy risk category D. Once pregnancy is detected, every effort should be made to discontinue.
QUINAPRIL/HYDROCOROTHIAZIDE - ORAL Accuretic side. This combination product contains two active ingredients: quinapril and hydrocorothiazide. Quinapril belongs to a class of medications ed ACE inhibitors and helps to lower blood pressure by relaxing blood vessels and reducing the workload of the heart. Consumer information about the medication QUINAPRIL/HYDROCOROTHIAZIDE - ORAL Accuretic, includes side effects, drug interactions, recommended.
Apo-Quinapril/HCTZ - Uses, Side Effects, Interactions - Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage WARNING: This drug can cause serious (possibly fatal) harm to an unborn baby if used during pregnancy. This combination product contains two active ingredients quinapril and hydrocorothiazide. It is used to treat hh blood pressure. Quinapril belongs to a class.
Aggrenox aspirin/dipyridamole dose, indications, adverse. Hydrocorothiazide is a diuretic or "water pill" that helps control blood pressure by getting rid of excess salt and water. Aggrenox is a combination product containing aspirin and dipyridamole. Dipyridamole is contraindicated in patients with a prior hypersensitivity to dipyridamole.
Accuretic Quinapril hydrocoride and Hydrocorothiazide Drug. Switching from quinapril monotherapy: initially one Accuretic 10/12.5 tab or one Accuretic 20/12.5 tab once daily; allow 2–3 weeks before increasing hydrocorothiazide component. Consumer Medicine Information CMI about Accuretic Quinapril hydrocoride and Hydrocorothiazide intended for persons living in Australia.
Accuretic quinapril/hydrocorothiazide dosing, indications. Quinapril hydrocorothiazide is a combination of two active ingredients. Medscape - Indication-specific dosing for Accuretic quinapril/hydrocorothiazide, frequency-based adverse effects, comprehensive interactions.
Quinapril / HCTZ Prices and Quinapril / HCTZ Coupons - GoodRx This combination medication is prescribed when your doctor feels it is appropriate for you to be taking both medications. QUINAPRIL; HYDROCOROTHIAZIDE is a combination of a diuretic and an ACE inhibitor. It is used to treat hh blood pressure. Compare ACE inhibitor.
Hydrocorothiazide and quinapril - CardioSmart Fosinopril/hydrocorothiazide (trade name Monopril HCT) has a boxed warning about its snificant risk to cause fetal/neonatal morbidity and mortality when being used during pregnancy (2nd and 3rd trimesters). Hydrocorothiazide is a thiazide diuretic water pill that helps prevent your body from absorbing too much salt, which can cause fluid retention. Quinapril is in a.
Quinapril and hydrochlorothiazide:
Rating: 99 / 100
Overall: 96 Rates